Latest Health research news from the around the globe: Medical Technology St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis Management Solutions at Transcatheter Cardiovascular Therapeutics (TCT) ================================================================================ admin on 23 September, 2009 02:45:00 St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company's portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics meeting in San Francisco. The featured products reflect the company's continued commitment to developing comprehensive, high-performance solutions which advance the practice of interventional cardiology by improving efficiencies and giving physicians more control. FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices ================================================================================ admin on 22 September, 2009 05:10:00 Awardees will work with industry and the FDA to address unmet pediatric device needs St. Jude Medical Announces FDA Approval of EnSite Velocity Cardiac Mapping System ================================================================================ admin on 14 September, 2009 02:40:00 Next-generation cardiac mapping system gives physicians the ability to increase procedural efficiency and speed for treating irregular heart rhythms St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease First patient implanted with Brio neurostimulator at University of Cologne, Germany ================================================================================ admin on 10 September, 2009 03:25:00 First patient implanted with Brio neurostimulator at University of Cologne, Germany Abbott Launches Next-Generation XIENCE PRIME™ Drug Eluting Stent in International Markets ================================================================================ admin on 01 September, 2009 02:32:00 —New Cobalt Chromium Stent Offers Enhanced Deliverability with a Broad Matrix of Sizes —Built Upon the Proven Track Record of Superior Clinical Outcomes of Abbott's Market-Leading XIENCE V® Drug Eluting Stent Infectious Disease and Bioterrorism: A New Model for Protection ================================================================================ admin on 26 August, 2009 12:42:00 UPMC and University of Pittsburgh leaders today proposed an innovative solution to the country’s pressing need to improve its vaccine-producing abilities. As recent events have shown, the spread of infectious diseases poses an ever-increasing threat to the U.S., and nearly every western government recognizes the need to strengthen its response against a bioterrorist attack. FDA Enhances Speed and Transparency of Actions Taken Against Misconduct in Drug and Device Development ================================================================================ admin on 08 August, 2009 01:48:00 The U.S. Food and Drug Administration today announced it has stepped up its efforts to prevent non-compliant investigators and others from participating in new product development. Hearing impaired get better hearing with cochlear implant plus hearing aid ================================================================================ admin on 06 August, 2009 02:03:00 By Gwen Ericson -- Adults with severe hearing loss benefit from pairing a cochlear implant in one ear with a hearing aid in the other ear, even though the sound signals from each device are very different, according to a study at Washington University School of Medicine in St. Louis published in the June issue of the Journal of the American Academy of Audiology. Researchers Effectively Treat Tumors with Use of Nanotubes ================================================================================ admin on 03 August, 2009 02:52:00 WINSTON-SALEM, N.C. – By injecting man-made, microscopic tubes into tumors and heating them with a quick, 30-second zap of a laser, scientists have discovered a way to effectively kill kidney tumors in nearly 80 percent of mice. Researchers say that the finding suggests a potential future cancer treatment for humans. Early Detection and Quick Response Are Key to Defense Against Anthrax Attack ================================================================================ admin on 27 July, 2009 03:29:00 Delays Could Overwhelm Hospitals, According to New Study by Weill Cornell Medical School Public Health Researchers